Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy

Clinical trial NCT05431595 · RECRUITING

Trial details

NCT number: NCT05431595
Sponsor: M.D. Anderson Cancer Center
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Delirium Epileptics Neuroleptics

Start date: 2022-07-19
Primary completion: 2027-02-02
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.